Q4 2024 Nutex Health Inc Earnings Call Transcript
Key Points
- Nutex Health Inc (NUTX) reported a significant revenue increase of 94% for the full year of 2024, reaching $479.9 million compared to $247.6 million in 2023.
- The company's adjusted EBITDA saw a remarkable growth of over 1,000%, rising from $10.8 million in 2023 to $123.7 million in 2024.
- Net income for 2024 was $52 million, a substantial improvement from a loss of $46 million in 2023.
- Patient volume increased by 17% in 2024, with mature hospitals contributing 6.5% to this growth.
- Nutex Health Inc (NUTX) successfully opened four new hospitals in 2024, expanding its network to 24 hospitals across 11 states.
- The implementation of the No Surprises Act (NSA) has negatively impacted revenue per patient reimbursement, with insurer payments for emergency services dropping by roughly 30%.
- The arbitration process, while beneficial, is costly, labor-intensive, and time-consuming, posing a financial and operational burden.
- Despite the opening of new hospitals, the current portion of long-term debt increased from $10.8 million in 2023 to $14 million in 2024.
- The arbitration process requires significant upfront costs, including Medicare administrative fees and arbitrator fees, which can be a financial strain.
- The company faces challenges in maintaining low costs and aggressive debt management amidst expansion and operational adjustments.
Greetings, and welcome to the Nutex Health fourth-quarter 2024 financial results call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Ms. Jennifer Rodriguez, Investor Relations for Nutex's Health. Please begin.
Good morning, everyone, and welcome to Nutex Health fourth-quarter and full-year 2024 earnings call. My name is Jennifer Rodriguez, and I'm happy to serve as your moderator today. We're truly grateful for your participation and your continued interest in our company as we share the highlights of an exceptional year.
Please note that this call is being recorded for future reference. Joining me this morning are some of the key leaders driving Nutex Health forward, our Chairman and CEO, Dr. Tom Vo; our Chief Financial Officer, Jon Bates; our President, Dr. Warren Hosseinion; and our Chief Operating Officer, Josh DeTillio.
Together, we'll provide prepared remarks to give you a comprehensive view of our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
